Killer activation receptor - Wikipedia
MICA/MICB Antibody, anti-human | Hybridomas | MACS Antibodies | Products | Miltenyi Biotec | USA
Frontiers | Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma
MICB - an overview | ScienceDirect Topics
MICB - an overview | ScienceDirect Topics
The MICA‐129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation | EMBO Molecular Medicine
Dual role of MICA/B as target molecule for immunosurveillance by NK... | Download Scientific Diagram
Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells | Journal of Experimental & Clinical Cancer Research | Full Text
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity | Science
Shedding MICA B Antigens
MICA/MICB antibody (CL750-65161) | Proteintech
Abstract # 3506
PE anti-human MICA/MICB
MICA/MICB antibody (Biotin-65161) | Proteintech
MICA/MICB antibody (PE-65161) | Proteintech
Cells | Free Full-Text | NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
T Cell Biology and Cancer Immunology - Dana-Farber Cancer Institute - Highlights - Wucherpfennig Lab - T Cell Biology and Cancer Immunology
MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner | Journal for ImmunoTherapy of Cancer | Full Text
MICA (MHC class I polypeptide-related sequence A)
NKG2D and MICA/B shedding: a 'tag game' between NK cells and malignant cells - Xing - 2020 - Clinical & Translational Immunology - Wiley Online Library
Anti-MICA and MICB Antibody Development - Creative Biolabs
Frontiers | NKG2D and Its Ligands: “One for All, All for One”
MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue | British Journal of Cancer
Cancers | Free Full-Text | Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response
Frontiers | Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity
